Shaklai M - Search Results

1

Expression of p53 in human leukemia and lymphoma.

Prokocimer M, Shaklai M, Bassat HB, Wolf D, Goldfinger N, Rotter V. Prokocimer M, et al. Among authors: shaklai m. Blood. 1986 Jul;68(1):113-8. Blood. 1986. PMID: 3521760 Free article.

2

BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation.

Blickstein D, Aviram A, Luboshitz J, Prokocimer M, Stark P, Bairey O, Sulkes J, Shaklai M. Blickstein D, et al. Among authors: shaklai m. Blood. 1997 Oct 1;90(7):2768-71. Blood. 1997. PMID: 9326244 Free article.

3

Primary malignant neoplasms associated with chronic lymphocytic leukaemia.

Lishner M, Prokocimer M, Ron E, Shaklai M. Lishner M, et al. Among authors: shaklai m. Postgrad Med J. 1987 Apr;63(738):253-6. doi: 10.1136/pgmj.63.738.253. Postgrad Med J. 1987. PMID: 3684832 Free PMC article.

4

ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.

Prokocimer M, Modan M, Rusoshansky S, Bairey O, Shaklai M. Prokocimer M, et al. Among authors: shaklai m. Anticancer Res. 1989 Jul-Aug;9(4):1233-5. Anticancer Res. 1989. PMID: 2479327

5

Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia.

Shaklai S, Bairey O, Blickstein D, Prokocimer M, Hadar H, Lahav M, Sulkes J, Shaklai M. Shaklai S, et al. Among authors: shaklai m. Cancer. 1996 Jun 1;77(11):2313-7. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2313::AID-CNCR20>3.0.CO;2-Z. Cancer. 1996. PMID: 8635101 Clinical Trial.

6

Autoimmunity in chronic lymphocytic leukaemia.

Lischner M, Prokocimer M, Zolberg A, Shaklai M. Lischner M, et al. Among authors: shaklai m. Postgrad Med J. 1988 Aug;64(754):590-2. doi: 10.1136/pgmj.64.754.590. Postgrad Med J. 1988. PMID: 3249703 Free PMC article.

7

Recombinant interferon alpha-C for advanced hairy cell leukemia. An Israeli multicenter study.

Aderka D, Michalevicz R, Daniel Y, Levo Y, Douer D, Ben-Bassat I, Ramot B, Shaklai M, Prokocimer M, Berrebi A, et al. Aderka D, et al. Among authors: shaklai m. Cancer. 1988 Jun 1;61(11):2207-13. doi: 10.1002/1097-0142(19880601)61:11<2207::aid-cncr2820611114>3.0.co;2-q. Cancer. 1988. PMID: 3365651

8

Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.

Bairey O, Gabbay U, Blickstein D, Stark P, Prokocimer M, Epstein O, Shaklai M, Lahav J. Bairey O, et al. Among authors: shaklai m. Hematol Oncol. 1997 Aug;15(3):121-7. doi: 10.1002/(sici)1099-1069(199708)15:3<121::aid-hon606>3.0.co;2-d. Hematol Oncol. 1997. PMID: 9600111

9

Hemophagocytosis simulating malignant histiocytosis: a terminal event of the myelodysplastic syndrome.

Prokocimer M, Inbal A, Gelber M, Shohat B, Ben Basat M, Shaklai M. Prokocimer M, et al. Among authors: shaklai m. Acta Haematol. 1985;74(3):164-7. doi: 10.1159/000206198. Acta Haematol. 1985. PMID: 3938160

10

Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients.

Aviram A, Blickstein D, Stark P, Luboshitz J, Bairey O, Prokocimer M, Shaklai M. Aviram A, et al. Among authors: shaklai m. Leuk Lymphoma. 1999 Mar;33(1-2):77-82. doi: 10.3109/10428199909093727. Leuk Lymphoma. 1999. PMID: 10194123 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters